RIA
CELU icon

RP Investment Advisors’s Celularity CELU Stock Holding History

RP Investment Advisors’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-165,326
Closed -$16.4M – 22
2019
Q4 		$16.4M Buy
+165,326
New +$16.4M 4.76% 4

Other funds holding CELU

Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

RP Investment Advisors's CELU Position: Q1 2020 in Review

RP Investment Advisors sold out of Celularity (CELU) in Q1 2020, closing a stake of 165,326 shares — an estimated $16.4M sold.

RP Investment Advisors first reported a position in CELU in Q4 2019 and held it in 1 quarter. The position peaked at $16.4M in Q4 2019. 35 funds tracked by Wall St. Rank hold CELU as of Q1 2020.

  • RP Investment Advisors reported no remaining Celularity position as of Q1 2020 after selling out during the quarter.
  • RP Investment Advisors sold 165,326 Celularity shares in Q1 2020, an estimated $16.4M.
  • RP Investment Advisors first reported a position in Celularity in Q4 2019 and held it in 1 quarter.
  • RP Investment Advisors's Celularity position peaked at $16.4M in Q4 2019.
  • 35 funds tracked by Wall St. Rank held Celularity as of Q1 2020.

Based on RP Investment Advisors's 13F filing for Q1 2020, filed 13 May 2020.